Sökning: onr:"swepub:oai:DiVA.org:umu-202430" > GBA and APOE impact...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04444naa a2200649 4500 | |
001 | oai:DiVA.org:umu-202430 | |
003 | SwePub | |
008 | 230109s2022 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-2024302 URI |
024 | 7 | a https://doi.org/10.1002/mds.289322 DOI |
040 | a (SwePub)umu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Szwedo, Aleksandra A4 aut |
245 | 1 0 | a GBA and APOE impact cognitive decline in Parkinson's disease :b A 10-year population-based study |
264 | c 2022-02-02 | |
264 | 1 | b John Wiley & Sons,c 2022 |
338 | a electronic2 rdacarrier | |
520 | a BACKGROUND: Common genetic variance in apolipoprotein E (APOE), β-glucocerebrosidase (GBA), microtubule-associated protein tau (MAPT), and α-synuclein (SNCA) has been linked to cognitive decline in Parkinson's disease (PD), although studies have yielded mixed results.OBJECTIVES: To evaluate the effect of genetic variants in APOE, GBA, MAPT, and SNCA on cognitive decline and risk of dementia in a pooled analysis of six longitudinal, non-selective, population-based cohorts of newly diagnosed PD patients.METHODS: 1002 PD patients, followed for up to 10 years (median 7.2 years), were genotyped for at least one of APOE-ε4, GBA mutations, MAPT H1/H2, or SNCA rs356219. We evaluated the effect of genotype on the rate of cognitive decline (Mini-Mental State Examanation, MMSE) using linear mixed models and the development of dementia (diagnosed using standardized criteria) using Cox regression; multiple comparisons were accounted for using Benjamini-Hochberg corrections.RESULTS: Carriers of APOE-ε4 (n = 281, 29.7%) and GBA mutations (n = 100, 10.3%) had faster cognitive decline and were at higher risk of progression to dementia (APOE-ε4, HR 3.57, P < 0.001; GBA mutations, HR 1.76, P = 0.001) than non-carriers. The risk of cognitive decline and dementia (HR 5.19, P < 0.001) was further increased in carriers of both risk genotypes (n = 23). No significant effects were observed for MAPT or SNCA rs356219.CONCLUSIONS: GBA and APOE genotyping could improve the prediction of cognitive decline in PD, which is important to inform the clinical trial selection and potentially to enable personalized treatment © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Neurologi0 (SwePub)302072 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Neurology0 (SwePub)302072 hsv//eng |
653 | a APOE | |
653 | a GBA | |
653 | a Parkinson's disease | |
653 | a cognitive decline | |
653 | a dementia | |
653 | a Human Anatomy | |
653 | a anatomi | |
653 | a nanomaterials | |
653 | a nanomaterial | |
700 | 1 | a Dalen, Ingvild4 aut |
700 | 1 | a Pedersen, Kenn Freddy4 aut |
700 | 1 | a Camacho, Marta4 aut |
700 | 1 | a Bäckström, David C,c M.D.d 1978-u Umeå universitet,Neurovetenskaper,Department of Neurology, and Department of Neuroscience, Yale University School of Medicine, New Haven, Connecticut, USA4 aut0 (Swepub:umu)dadbam02 |
700 | 1 | a Forsgren, Larsu Umeå universitet,Neurovetenskaper4 aut0 (Swepub:umu)lafo0001 |
700 | 1 | a Tzoulis, Charalampos4 aut |
700 | 1 | a Winder-Rhodes, Sophie4 aut |
700 | 1 | a Hudson, Gavin4 aut |
700 | 1 | a Liu, Ganqiang4 aut |
700 | 1 | a Scherzer, Clemens R4 aut |
700 | 1 | a Lawson, Rachael A4 aut |
700 | 1 | a Yarnall, Alison J4 aut |
700 | 1 | a Williams-Gray, Caroline H4 aut |
700 | 1 | a Macleod, Angus D4 aut |
700 | 1 | a Counsell, Carl E4 aut |
700 | 1 | a Tysnes, Ole-Bjørn4 aut |
700 | 1 | a Alves, Guido4 aut |
700 | 1 | a Maple-Grødem, Jodi4 aut |
710 | 2 | a Umeå universitetb Neurovetenskaper4 org |
773 | 0 | t Movement Disordersd : John Wiley & Sonsg 37:5, s. 1016-1027q 37:5<1016-1027x 0885-3185x 1531-8257 |
856 | 4 | u https://doi.org/10.1002/mds.28932y Fulltext |
856 | 4 | u https://umu.diva-portal.org/smash/get/diva2:1724886/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28932 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-202430 |
856 | 4 8 | u https://doi.org/10.1002/mds.28932 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy